In Japan, the number of patients with streptococcal toxic shock syndrome is reported to be increasing. mef(A) gene-positive macrolide-resistant emm1 strains are thought to possibly contribute to the rise in the frequency of STSS. Although analyses of macrolide-resistant mechanisms, including mef(A) resistance, have been performed mainly in Streptococcus pneumoniae, the role of this gene in Streptococcus pyogenes has not been completely investigated. Therefore, to the best of our knowledge, we established the first mef(A)-knockout strain using an emm1-type S. pyogenes strain, and tested its susceptibility to erythromycin, clarithromycin and azithromycin. We found that the antimicrobial susceptibilities were almost identical to those of the parental strain. Hence, we established a knockout strain for another gene, msr(D), that is located immediately downstream of mef(A). The macrolide resistances of the resulting strain significantly decreased, and were further altered when both mef(A) and msr(D) were knocked out. The introduction of the msr(D) gene into a macrolide-sensitive strain conferred more resistance than the introduction of the mef(A) gene. The erythromycin susceptibilities of knockout strains were further dissected using two additional emm4and emm75-type S. pyogenes strains. We found almost identical results for both strains except for the mef(A) knockout emm4 type, whose susceptibility was altered, although the change was less than that for the msr(D) knockout. These results suggest that both mef(A) and msr(D) are involved in macrolide resistance in S. pyogenes, and that the msr(D) gene plays a more predominant role in macrolide resistance than mef(A).
INTRODUCTION
Streptococcus pyogenes is a Gram-positive bacterium that causes mild (e.g. pharyngitis, impetigo and scarlet fever), invasive [e.g. bacteraemia/septicaemia, necrotizing fasciitis, and streptococcal toxic shock syndrome (STSS)] and nonsuppurative (e.g. rheumatic fever and glomerulonephritis) infections (Cunningham, 2000) .
Epidemiological analyses have revealed that emm1-type S. pyogenes is the most commonly detected type in patients in high-income continents, such as Europe and North America, and countries such as Japan (Steer et al., 2009) . Moreover, in Japan, the emm1 type is the most frequently isolated type in invasive S. pyogenes infections (Ikebe et al., 2003; Wajima et al., 2008) and the number of patients with STSS has increased recently (http://www.nih.go.jp/niid/ja/ all-surveillance/2085-idwr/ydata/4405-report-ja2012.html). In particular, the rise in the incidence of STSS was reported to be attributable to an increase in the number of cases associated with specific mef(A)-positive emm1 isolates (Ikebe et al., 2015) .
In Japan, macrolides are widely used for the treatment of S. pyogenes infection and several macrolide-resistant strains have been isolated (Hotomi et al., 2005; Giovanetti et al., 2005; Wajima et al., 2008) . One of the mechanisms of erythromycin resistance is caused by target-site modification On: Fri, 21 Dec 2018 14:20:23 by an rRNA-methylating enzyme that is encoded by erm(B) or erm(A) (Weisblum, 1995; Sutcliffe et al., 1996; Seppälä et al., 1998) , which results in resistance to macrolide, lincosamide and streptogramin B antibiotics. Another mechanism is the active efflux of erythromycin. The mef(A) gene was first cloned from S. pyogenes and it was suggested that it encoded a membrane-associated antiporter protein, which pumps all 14-and 15-membered macrolides including erythromycin out of the cell (Clancy et al., 1996) . Since then, a tight relationship between macrolide resistance and the presence of the mef(A) Orden et al., 1998) , erm(B) and erm(A) genes (Kataja et al., 1999) has been reported. However, several studies have mainly investigated Streptococcus pneumoniae and the role of the mef(A) gene in macrolide resistance in S. pyogenes has not been fully revealed. In addition, we studied the msr(D) gene because it is located immediately downstream of the mef(A) gene, and co-exists in the conjugative prophage W1207.3 (Iannelli et al., 2014) , W10394.4 (Banks et al., 2003) , Wm46.1 (Brenciani et al., 2010) and other related elements (Vitali et al., 2015) in S. pyogenes. Furthermore, mef(A) and msr(D) genes were reported to be co-identified in erythromycin-resistant S. pyogenes (Brenciani et al., 2004; Rubio-Ló pez et al., 2012; Iannelli et al., 2014) . In this study, we established mef(A)-and msr(D)-knockout strains, and examined their roles in macrolide resistance in S. pyogenes.
METHODS
Isolates. The macrolide-resistant emm1-type S. pyogenes strain 10-85 isolated from an STSS patient in 2010 (Okada et al., 2014) was used for the knockout experiments. The genome data of 10-85 was deposited in DDBJ/GenBank (accession number SAMD00034931). The emm75-type NCU107 and emm4-type NCU115 strains were isolated from pharyngitis patients in 2008 and also used for knockout experiments. The macrolide-resistant erm(B)-positive emm1-type 14-T-4 strain and erm(A)-positive emm1-type NCU41 strain were used for PCR analyses. The 1529 STSS strain was used as a representative macrolide-sensitive strain (Hasegawa et al., 2010b) .
Culture conditions. Bacteria were cultured in a brain heart infusion broth (Eiken Chemical) supplemented with 0.3 % yeast extract (Becton Dickinson) (BHI-YE) at 37 uC without agitation. The growth of the bacteria was monitored using a colorimeter (Asahi Science) at OD 660 .
Assessment of growth of bacteria exposed to erythromycin. An aliquot of 10-85 and its mef(A)-knockout strain stock solution stored frozen at 280 uC was inoculated into 3 ml BHI-YE and pre-cultured overnight at 30 uC without agitation. Then, 36 ml overnight culture was added to 3.6 ml BHI-YE with 1 mg erythromycin l 21 and cultured at 37 uC without agitation. The turbidity of the strains was monitored at OD 660 at the indicated time points (2, 3, 4, 5, 6, 7 and 24 h after starting the culture).
Detection of macrolide resistance-related genes. The mef(A), erm(B), erm(A) and msr(D) genes were detected by PCR using Ex Taq DNA polymerase (TaKaRa). The primers used (mef-n1/c1, msr-n4/ c4, ermB-F/R and ermA-F/R) (Sutcliffe et al., 1996; Seppälä et al., 1998) Drug susceptibility experiment. The MICs of erythromycin, azithromycin and clarithromycin were determined using the Etest method. The Etest was performed in accordance with the manufacturer's instructions (SYSMEX bioMérieux). In brief, the inoculum concentration was adjusted to 0.5 in the McFarland standard for the WT and mutant types. The diluted samples were inoculated onto Mueller-Hinton agar with 5 % sheep blood by swabbing over the entire surface in three directions. In the case of the analyses of complemented strains, the MICs were analysed using BHI-YE agar plates, without sheep blood, containing 100 mg kanamycin l 21 to keep the transformed plasmid. After a period of 15 min, three kinds of macrolide antibiotic Etest strips (erythromycin, azithromycin and clarithromycin) were applied. The plates were incubated at 35 uC in air containing 5 % CO 2 and read after 24 h. The MICs and minimum concentrations in the complementation experiments of all strains were read where the ellipse of growth inhibition was intersected by the strip. The independent Etest experiment was repeated three times. The significances were determined using Student's t-test.
Establishment of knockout and complemented strains. Nonpolar inactivated mutants of the mef(A) and/or msr(D) gene were constructed through double-crossover allelic replacement in the chromosome of S. pyogenes emm1-type 10-85, emm75-type NCU107 and emm4-type NCU115. For the construction of the plasmid for the mef(A) knockout, the DNA fragment of mef(A) was amplified with oligonucleotide primers mef-n9Sma I and mef-c3 (Table 1 , Fig. 1 ) (fragment 1). The Sma I/Dra I-digested fragment 1 was subcloned into the Sma I site of the pFW12 vector (Lukomski et al., 2000) (named pTH643). A second round of PCR was performed using mef-n8Nhe I and mef-c9 (Table 1 , Fig. 1 ) (fragment 2). Both the Nhe I-digested fragment 2 and the spc1 DNA fragment containing aad9 (promoterless spectinomycin resistance gene) obtained from a Sma I-digested fragment of pSL60-1 (Lukomski et al., 2000) were cloned into the Nhe I/Sma I site of pTH643 (named pTH647). For the construction of the plasmid for the msr(D) knockout, the DNA fragment of msr(D) was amplified with oligonucleotide primers msr-n2Sma I and msr-c2 (Table 1, Fig. 1 ) (fragment 3). The Sma I-digested fragment 3 was subcloned into the Sma I site of the pFW12 vector (named pTH676). The final round of PCR was performed using msr-n1Nhe I and msr-c1 (Table 1 , Fig. 1 ) (fragment 4). Both the Nhe I-digested fragment 4 and the spc3 DNA fragment containing aad9 obtained from a Sma Idigested fragment of pSL60-3 (Lukomski et al., 2000) were cloned into the Nhe I/Sma I site of pTH676 (named pTH677). For the construction of the plasmid for both the mef(A) and msr(D) double knockout, both the Nhe I-digested fragment 2 and the spc3 DNA fragment were cloned into the Nhe I/Sma I site of pTH676 (named pTH678). These plasmids, pTH647, pTH677 and pTH678, were suicide vectors for S. pyogenes.
To construct a plasmid for mef(A) complementation, the DNA fragment of mef(A) was amplified with oligonucleotide primers mef-n2 and mef-c3 with PrimeSTAR HS DNA Polymerase (TaKaRa). To construct a plasmid for msr(D) complementation, the DNA fragment of msr(D) was amplified with oligonucleotide primers msr-n1Nhe I and msr-c2 with PrimeSTAR HS DNA Polymerase. The fragments were treated with T4 polynucleotide kinase and then inserted into the Sma I site of the pLZ12-Km2 plasmid (Okada et al., 1998) with ligase.
The method to prepare competent cells and the electroporation conditions were identical to those published previously (Hasegawa et 
RESULTS
Establishment of the mef(A)-knockout strain and analysis of drug susceptibility Although many studies have described the relevance of mef(A) in macrolide resistance in S. pyogenes, we could not find studies in the literature using a mef(A)-knockout S. pyogenes strain. Hence, we attempted to establish a mef(A)-knockout strain using the emm1-type macrolideresistant 10-85 strain, because it possesses a single copy of the mef(A) gene and neither the erm(B) nor the erm(A) genes in the genome. We succeeded in establishing a mef(A)-knockout strain and performed an Etest. No significant differences in MICs of erythromycin, clarithromycin and azithromycin between the parental strain and its mef(A)-knockout strain were detected (P50.5185, 1 and 0.1161, respectively; Table 2 ), suggesting that other factor(s) could compensate for macrolide resistance by mef(A). To confirm that the role of mef(A) was fully compensated by other factor(s), we checked the growth of both the 10-85 WT and its mef(A)-knockout strain, with and without erythromycin (1 mg l 21 ). As shown in Fig. 2 , the growth curves of the WT and the mef(A)-knockout 
ermA-F GAAGTTTAGCTTTCCTAA ermA-R GCTTCAGCACCTGTCTTAATTG strain, without erythromycin, were almost the same.
Although the turbidity of the mutant strain reached the same level as that of the WT strain at the 24 h time point in the presence of erythromycin, it was obvious that the growth of the mef(A)-knockout strain was slower than that of the WT, suggesting that the role of mef(A) was not completely compensated for by other factor(s).
Establishment of the msr(D)-knockout strain and analysis of drug susceptibility
The mef(A) gene is reported to be present with its adjacent msr(D) gene in the conjugative prophage W1207.3 (formerly Tn1207.3) (Santagati et al., 2003; Iannelli et al., 2014) , W10394.4 (Banks et al., 2003) and Wm46.1 (Brenciani et al., 2010) . The genome data for strain 10-85 showed the presence of a single copy of the msr(D) gene. Hence, we focused on msr(D) because this gene was shown to be involved in macrolide resistance in S. pneumoniae (Santagati et al., 2000; Ambrose et al., 2005; Gay & Stephens, 2001) . We established the msr(D)knockout strain and performed an Etest. The data from the Etest with erythromycin showed that the sensitivity of the msr(D) mutant was significantly different from the parental strain (P50.0005; Table 2 ). The data from the Etest with azithromycin and clarithromycin also showed a striking difference between the parental strain and the msr(D) mutant (P50.0007 and 0.0014, respectively; Table 2 ). To confirm these results, complementation experiments were performed. In these experiments, BHI-YE agar plates without sheep blood containing 100 mg kanamycin l 21 were used. Hence, the MIC of erythromycin for 10-85 transformed with pLZ12 plasmid was different from the MIC for WT 10-85 in Table 2 . As shown in Table 3 , msr(D) complementation rescued the resistance in the msr(D)-knockout strain (P50.0167), suggesting this gene is indispensable and that mef(A) and/or other factor(s) could not compensate for macrolide resistance by msr(D) knockout.
Establishment of the mef(A)or msr(D)complemented strains and analysis of drug susceptibility
We introduced the mef(A) or msr(D) gene into a 1529 macrolide-sensitive strain and analysed the drug sensitivity of the complemented strains using the Etest. In this experiment, we also used BHI-YE agar plates without sheep blood containing 100 mg kanamycin l 21 to analyse the function of these genes. Hence, the values are not the real MICs assayed by the standard method. As shown in Table 4 , the msr(D)-complemented strain was more resistant to erythromycin than the parental strain (P50.0022); 
Establishment of mef(A) -msr(D) doubleknockout strain and analysis of drug susceptibility
We established a mef(A)-msr(D) double-knockout strain. Erythromycin, clarithromycin and azithromycin susceptibilities of the mef(A)-msr(D) double-knockout strain were significantly different from those of the msr(D) mutant strains by the Etest (Table 2) . Each mef(A) and msr(D) gene rescued resistance in the mef(A)-msr(D) double-knockout strain (Table 3 ). These results suggest that both genes collaborate in macrolide resistance.
Assessment of the results from the emm1 type in other emm-type S. pyogenes
We tried to assess the results obtained from the 10-85 emm1-type S. pyogenes in other emm-type S. pyogenes. We screened many macrolide-resistant isolates by PCR, and found several isolates that possessed both mef(A) and msr(D) genes, but no erm(B) and erm(A) genes. We tried to establish mef(A)-, msr(D)-and mef(A)-msr(D)-knockout strains, and succeeded in the establishment of all three knockout strains from emm75-type NCU107 and emm4type NCU115 strains. We checked that the amino acid sequences of Msr(D) of these strains deduced from nucleotide sequences were completely identical to that of 10-85, but aa 209 from the start methionine of Mef(A) in both strains was lysine instead of the glutamine in 10-85. The erythromycin Etest was performed and the same results were obtained from NCU107 (Table 5 ). The sensitivity of the NCU115 mef(A) knockout was altered, albeit the change in msr(D) was more significant ( Table 5 ), suggesting that the predominance of msr(D) was confirmed in other emm-type S. pyogenes examined. However, compensation mechanisms in the absence of mef(A) could be different amongst the strains with different emm types.
DISCUSSION
Since the mef(A) gene was first cloned from S. pyogenes (Clancy et al., 1996) , the tight relationship between macrolide resistance and presence of the mef(A) gene has been reported Orden et al., 1998) , and a crucial role of mef(A) in macrolide resistance is irrefutable. Clancy et al. (1996) concluded that mef(A) was responsible for erythromycin resistance because (1) an Escherichia coli strain containing mef(A) maintained a lower level of intracellular erythromycin compared with the isogenic E. coli strain and (2) the intracellular accumulation of [ 14 C]erythromycin in erythromycin-resistant S. pyogenes strains Table 3 . Susceptibilities of the complemented strains by Etest P-values determined using Student's t-test: *P.0.05 and P50.0004 when compared with the WT strain NCU107 and strain NCU107 Dmef(A)-msr(D), respectively; DP50.0019 and P50.0167 when compared with the WT strain NCU107 and strain NCU107 Dmef(A)msr(D), respectively; dP55.52610 25 when compared with the WT strain NCU107; §P50.0022 and P50.0004 when compared with the WT strain NCU115 and strain NCU115 Dmef(A)-msr(D), respectively; ||P50.0007, P50.0010 when compared with the WT strain NCU115 and strain NCU115 Dmef(A)-msr(D), respectively; "P50.0006 when compared with the WT strain NCU115. was always lower than that observed in sensitive S. pyogenes strains. Furthermore, they stated that their hypothesis should be substantiated by creating mef(A)-knockout S. pyogenes strains (Clancy et al., 1996) . To the best of our knowledge, however, there have been no such published reports that directly confirmed the relationship between mef(A) and macrolide resistance in S. pyogenes, although mef(E) was analysed using S. pneumoniae (Ambrose et al., 2005) .
In this study, first, we examined the roles of mef(A) in macrolide resistance in an emm1-type S. pyogenes clinical isolate by using a derivative knockout strain and found that the MICs of the mef(A)-knockout strain for macrolides were almost the same as that of its parental strain, but growth in the presence of erythromycin was suppressed. Second, the macrolide susceptibility of the msr(D)-knockout strain was significantly different from that of its parental strain. Finally, introduction of msr(D) into a macrolide-sensitive strain conferred drug resistance, unlike mef(A). From these results, we suggest that the msr(D) gene can almost compensate for the mef(A) function; however, the reverse is not true. Thus, mef(A) does not play dominant roles in macrolide-resistant emm1type S. pyogenes, but msr(D) is predominant. By using other emm-type S. pyogenes strains, we confirmed that the conclusion obtained from the data from emm1 is universal across all S. pyogenes strains.
msr(D) has been mainly studied in S. pneumoniae. In S. pneumoniae, the msr(D) gene is located adjacent to the mef gene as ORF5, and mel in Tn1207.1, and the mega element (Santagati et al., 2000; Gay & Stephens, 2001) . This has homology with the msr(A) gene cloned from Staphylococcus epidermidis (Ross et al., 1990) . The common regulatory mechanism is considered to be conserved in mef-msr-containing elements in a wide variety of Gram-positive bacteria (Chancey et al., 2015) . An msr pump was reported to potentially contribute to the efflux phenotype (Daly et al., 2004) . Ambrose et al. (2005) showed that macrolide efflux in S. pneumoniae was mediated by a dual-efflux pump, mef(E) and mel (msr). Etest erythromycin MICs were significantly reduced for both independent mef(E) (13-fold) and mel (22-fold) deletion mutants compared with those of the parental strains (Ambrose et al., 2005) . The significant reduction for independent mef(E) may be coincident with our result from the emm4type NCU115 strain. However, it is not coincident with our result from emm1-type and emm75-type S. pyogenes. In these two S. pyogenes strains, the erythromycin susceptibilities between the parental strain and the mef(A) knockout were not significantly different, but the erythromycin susceptibilities of msr(D) were significantly different. Although the growth of the emm1-type mef(A)-knockout strain was suppressed in the presence of a low concentration of erythromycin, the ability to compensate for factor(s) other than mef(A) could be more potent in S. pyogenes than S. pneumoniae. As the nucleotide sequences of msr(D) of emm1-type 10-85, emm4-type NCU115 and emm75-type NCU107 strains are identical, the existence of different uncharacterized factor(s) that may contribute or support the msr(D)/mef(A) system in S. pyogenes is a possibility.
In conclusion, we present data showing that msr(D) plays a predominant role over mef(A) in macrolide resistance in S. pyogenes. Further analyses are necessary to completely reveal the mechanism of macrolide resistance in S. pyogenes, particularly the different mechanisms between S. pyogenes and S. pneumoniae.
